Results 131 to 140 of about 121,678 (291)
How do Individuals with Complete Androgen Insensitivity Syndrome, Mayer-Rokitansky-Küster-Hauser Syndrome or Polycystic Ovary Syndrome Experience Contact to Other Affected Persons? [PDF]
, 2012 Kerstin Krupp +5 more
openalex +1 more source
Diabetic Medicine, EarlyView.Abstract Aims To evaluate the impact of obesity, with or without gestational diabetes mellitus (GDM), on adverse maternal outcomes and determine whether the combination of obesity and GDM confers a greater risk compared to obesity alone. Methods We systematically searched MEDLINE, EMBASE, Scopus, CINAHL and the WoS Core Collection, identifying 19 ...
Tessa L. Weir +2 more
wiley +1 more source
Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
, 2021 Semra Eroğlu +1 more
openalex +1 more source
Individual 17-Hydroxyprogesterone Responses to hCG Are Not Correlated With Follicle Size in Polycystic Ovary Syndrome. [PDF]
, 2019 Context:In women with polycystic ovary syndrome (PCOS), 17-hydroxyprogesterone (17-OHP) responses to gonadotropin stimulation vary from increased to indistinguishable compared with normal controls.
Chang, R Jeffrey +5 more
core +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims We evaluated the weight loss efficacy and safety of a national digital weight loss service (DWLS) and explored associations between digital engagement and outcomes in adults prescribed dual GIP/GLP‐1RA and GLP‐1RA. Materials and Methods We conducted a retrospective longitudinal cohort analysis of adults prescribed dual GIP/GLP‐1RA and GLP‐
Hans Johnson +3 more
wiley +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura +18 more
wiley +1 more source
Journal of Advanced Nursing, EarlyView.ABSTRACT Background More than 12% of women worldwide are affected by polycystic ovary syndrome (PCOS), whose symptoms are similar to those of puberty, often leading to delayed diagnosis and missing the opportunity for early intervention. This not only puts PCOS women under physical and mental stress but also reduces their trust in doctors and makes ...
Baoying Zhang, Joan Lalor
wiley +1 more source
The Clinical Particularities in Forming of Policystic Ovary Syndrome
Медицинский вестник Юга России, 2011 Purpose: Clinical particularities and conditions of the vegetative nervous system from the patients with forming polycystic ovary syndrome were studied.Materials and Methods: 364 patients aged 16-18 years old with forming polycystic ovary syndrome were ...
J. J. Chebotareva
doaj
Authors’ Response: Troglitazone Use in Polycystic Ovary Syndrome [PDF]
, 2001 Ricardo Azziz +7 more
openalex +1 more source